Luoxin Pharmaceutical
0027934.621.54% ( +0.07 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Luoxin Pharmaceutical(002793) the Revenue is 582.73 M (+20.72%);the EBIT is 45.97 M (+15.4%);the EPS is 0.0226 (+326.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.58B20.72%
----
----
EBIT
0.05B15.40%
----
----
EPS
0.0226326.42%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf